Skip to main content
HITIQ LIMITED logo

HITIQ LIMITED — Investor Relations & Filings

Ticker · HIQ ISIN · AU0000148967 ASX Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2022-06-21 Regulatory Filings
Country AU Australia
Listing ASX HIQ

About HITIQ LIMITED

https://www.hitiq.com

HITIQ Limited is a technology company focused on the assessment and management of head impact and concussion-related injuries. The company develops an end-to-end digital ecosystem designed to monitor brain health across various athletic and clinical environments. Its core technology includes a proprietary smart mouthguard embedded with high-fidelity sensors that capture and transmit head impact data in real-time. This hardware is integrated with a cloud-based analytics platform that provides stakeholders, such as medical professionals and coaching staff, with actionable insights into impact frequency and intensity. HITIQ's product suite also encompasses clinical assessment tools and recovery management protocols to support informed decision-making regarding player safety and return-to-play timelines. The company serves professional sports organizations, amateur leagues, and educational institutions.

Recent filings

Filing Released Lang Actions
HIQ Extends Concussion Assessment Agreement with NZ Rugby 2 pages 142.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 22 June 2022 about HITIQ extending a concussion assessment technology agreement with New Zealand Rugby. It describes the details of the agreement, the technology involved, and includes comments from the CEO. There are no financial statements, no regulatory certifications, no voting results, no management or board changes, no earnings data, and no mention of report attachments or filings. The document is a corporate announcement about a business agreement and partnership extension, not a financial report or regulatory filing. It fits best under the category of a general regulatory announcement or corporate update that does not fit other specific categories, which corresponds to Regulatory Filings (RNS). The document length is 4273 characters, which is relatively short and typical for an announcement rather than a full report.
2022-06-21 English
HITIQ to receive $2m R&D Finance 2 pages 133.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement about HITIQ Limited entering into a non-dilutive funding agreement to receive early access to forecast FY22 R&D Tax Incentive funds. It discusses the loan facility, repayment timing, and the company's financial strategy. There are no financial statements, detailed financial results, or comprehensive report content. The document is short (2422 characters) and serves as a capital/financing update rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2022-06-14 English
Quarterly Report and Appendix 4C 9 pages 296.7KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'HITIQ Quarterly Activities Report – March 2022' and provides a detailed update on the company's activities for the quarter ended 31 March 2022. It includes operational highlights, customer markets, technology updates, corporate financials, and an Appendix 4C which is a quarterly cash flow report required by ASX Listing Rule 4.7B. The presence of actual financial data such as cash flows from operating, investing, and financing activities, as well as cash reserves, confirms this is a comprehensive quarterly financial report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-04-28 English
HITIQ Establishes Scientific and Medical Advisory Council 4 pages 217.3KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 27 April 2022 about HITIQ establishing a Scientific and Medical Advisory Council. It details the formation of the council, its members, their biographies, and the strategic purpose of the council. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, no legal proceedings, no merger or acquisition activity, and no executive compensation details. The document is a corporate announcement about management and advisory structure, specifically about the establishment of a new advisory council. This fits best under Board/Management Information (MANG) as it relates to changes or additions in the company's advisory and management structure. The document length is substantial and contains detailed information about the council members, supporting the classification as a substantive announcement rather than a brief notice or regulatory filing.
2022-04-26 English
Notification of cessation of securities - HIQ 5 pages 25.4KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of securities, specifically performance rights that have lapsed due to conditions not being met. It details the number of securities ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement related to changes in the company's issued capital and securities status, not a full financial report or detailed management discussion. It does not contain financial statements or detailed analysis but is a regulatory announcement about securities status changes. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-03-30 English
Change of Director's Interest Notice 4 pages 85.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number and class of securities before and after the change, nature of the change, and related contractual interests. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or management discussion. Therefore, it fits the category of Director's Dealing filings, which report insider trades by directors and executives.
2022-03-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.